Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28421 | 169 | 29.7 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1071 | 9469 | ENTAMOEBA HISTOLYTICA//TRICHOMONAS VAGINALIS//ENTAMOEBA DISPAR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NITAZOXANIDE | Author keyword | 43 | 50% | 37% | 62 |
2 | TIZOXANIDE | Author keyword | 21 | 90% | 5% | 9 |
3 | HEPATOL GASTROENTEROL INFECT DIS | Address | 3 | 43% | 4% | 6 |
4 | THIAZOLIDES | Author keyword | 2 | 38% | 3% | 5 |
5 | NICLOSAMIDE | Author keyword | 2 | 13% | 8% | 13 |
6 | CRYPTONAZ POWDER | Author keyword | 1 | 100% | 1% | 2 |
7 | HCV REPLICON SYSTEM | Author keyword | 1 | 100% | 1% | 2 |
8 | UNIDAD INVEST MED YUCATAN | Address | 1 | 17% | 4% | 6 |
9 | MED NACL IGNACIO GARCIA TELLEZ | Address | 1 | 25% | 2% | 3 |
10 | CYTOTOXICITY IN VITRO ASSAY | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NITAZOXANIDE | 43 | 50% | 37% | 62 | Search NITAZOXANIDE | Search NITAZOXANIDE |
2 | TIZOXANIDE | 21 | 90% | 5% | 9 | Search TIZOXANIDE | Search TIZOXANIDE |
3 | THIAZOLIDES | 2 | 38% | 3% | 5 | Search THIAZOLIDES | Search THIAZOLIDES |
4 | NICLOSAMIDE | 2 | 13% | 8% | 13 | Search NICLOSAMIDE | Search NICLOSAMIDE |
5 | CRYPTONAZ POWDER | 1 | 100% | 1% | 2 | Search CRYPTONAZ+POWDER | Search CRYPTONAZ+POWDER |
6 | HCV REPLICON SYSTEM | 1 | 100% | 1% | 2 | Search HCV+REPLICON+SYSTEM | Search HCV+REPLICON+SYSTEM |
7 | CYTOTOXICITY IN VITRO ASSAY | 1 | 50% | 1% | 1 | Search CYTOTOXICITY+IN+VITRO+ASSAY | Search CYTOTOXICITY+IN+VITRO+ASSAY |
8 | HYBRID LINEAR ION TRAP ORBITRAP MASS SPECTROMETER | 1 | 50% | 1% | 1 | Search HYBRID+LINEAR+ION+TRAP+ORBITRAP+MASS+SPECTROMETER | Search HYBRID+LINEAR+ION+TRAP+ORBITRAP+MASS+SPECTROMETER |
9 | HYMENOLEPIASIS | 1 | 50% | 1% | 1 | Search HYMENOLEPIASIS | Search HYMENOLEPIASIS |
10 | NITAZOXANIDE NTZ | 1 | 50% | 1% | 1 | Search NITAZOXANIDE+NTZ | Search NITAZOXANIDE+NTZ |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TIZOXANIDE | 45 | 83% | 15% | 25 |
2 | INTESTINAL PROTOZOAN | 19 | 80% | 7% | 12 |
3 | THIAZOLIDES | 17 | 63% | 10% | 17 |
4 | HELMINTHIC INFECTIONS | 12 | 52% | 10% | 17 |
5 | ANTIPARASITIC DRUG NITAZOXANIDE | 9 | 83% | 3% | 5 |
6 | CRYPTOSPORIDIAL DIARRHEA | 1 | 18% | 4% | 7 |
7 | NTZ | 1 | 100% | 1% | 2 |
8 | THIAZOLIDE THIADIAZOLIDE DERIVATIVES | 1 | 100% | 1% | 2 |
9 | IN VITRO EFFICACIES | 1 | 23% | 2% | 3 |
10 | LIPOPHILIC EFFICIENCY | 1 | 22% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Nitazoxanide: A first-in-class broad-spectrum antiviral agent | 2014 | 5 | 49 | 67% |
Nitazoxanide - A review of its use in the treatment of gastrointestinal infections | 2007 | 62 | 64 | 48% |
Nitazoxanide: A new thiazolide antiparasitic agent | 2005 | 119 | 36 | 67% |
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C | 2008 | 14 | 22 | 82% |
Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections | 2006 | 51 | 50 | 54% |
Thiazolides: a new class of antiviral drugs | 2009 | 12 | 36 | 61% |
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug | 2014 | 10 | 71 | 13% |
Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells | 2012 | 11 | 16 | 19% |
New therapeutic approaches to hepatitis C virus | 2009 | 11 | 60 | 8% |
A functional perspective of nitazoxanide as a potential anticancer drug | 2014 | 0 | 70 | 10% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEPATOL GASTROENTEROL INFECT DIS | 3 | 43% | 3.6% | 6 |
2 | UNIDAD INVEST MED YUCATAN | 1 | 17% | 3.6% | 6 |
3 | MED NACL IGNACIO GARCIA TELLEZ | 1 | 25% | 1.8% | 3 |
4 | POS MATEMAT | 1 | 50% | 0.6% | 1 |
5 | ROMARK | 1 | 50% | 0.6% | 1 |
6 | UNIDAD PROTEOM MED | 1 | 50% | 0.6% | 1 |
7 | UP JE 2008 | 1 | 50% | 0.6% | 1 |
8 | VET DRUG SAFETY EVALUAT IDUE | 1 | 50% | 0.6% | 1 |
9 | PK PD CORE | 0 | 33% | 0.6% | 1 |
10 | BIOENGN MAT SCI ENGN | 0 | 15% | 1.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000094783 | GIARDIA DUODENALIS//GIARDIA LAMBLIA//GIARDIA |
2 | 0.0000080697 | SATRANIDAZOLE//AROYLHYDRAZINES//BIOCIS CHIM THER EUT |
3 | 0.0000073287 | CRYPTOSPORIDIUM//CRYPTOSPORIDIUM PARVUM//CRYPTOSPORIDIOSIS |
4 | 0.0000067204 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |
5 | 0.0000065249 | CORTISOL METABOLITE//GLUCRONIDE//PHAMACOL THER EUT |
6 | 0.0000063480 | BLASTOCYSTIS//BLASTOCYSTIS HOMINIS//DIENTAMOEBA FRAGILIS |
7 | 0.0000062658 | IN VITRO ANTIMYCOBACTERIAL ACTIVITY//SPINACH CHLOROPLASTS//DIAGNOST MYCOBACTERIA |
8 | 0.0000054211 | BESNOITIA BESNOITI//BESNOITIOSIS//BOVINE BESNOITIOSIS |
9 | 0.0000052168 | SOIL TRANSMITTED HELMINTHS//TRICHURIS TRICHIURA//HOOKWORM |
10 | 0.0000050400 | METRONIDAZOLE//TINIDAZOLE//NITROIMIDAZOLES |